Almeida MR - Search Results

1

Molecular tweezers targeting transthyretin amyloidosis.

Ferreira N, Pereira-Henriques A, Attar A, Klärner FG, Schrader T, Bitan G, Gales L, Saraiva MJ, Almeida MR. Ferreira N, et al. Among authors: almeida mr. Neurotherapeutics. 2014 Apr;11(2):450-61. doi: 10.1007/s13311-013-0256-8. Neurotherapeutics. 2014. PMID: 24459092 Free PMC article.

2

Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.

Almeida MR, Macedo B, Cardoso I, Alves I, Valencia G, Arsequell G, Planas A, Saraiva MJ. Almeida MR, et al. Biochem J. 2004 Jul 15;381(Pt 2):351-6. doi: 10.1042/BJ20040011. Biochem J. 2004. PMID: 15080795 Free PMC article.

3

Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design.

Cardoso I, Almeida MR, Ferreira N, Arsequell G, Valencia G, Saraiva MJ. Cardoso I, et al. Among authors: almeida mr. Biochem J. 2007 Nov 15;408(1):131-8. doi: 10.1042/BJ20070689. Biochem J. 2007. PMID: 17683281 Free PMC article.

4

Iodination of salicylic acid improves its binding to transthyretin.

Gales L, Almeida MR, Arsequell G, Valencia G, Saraiva MJ, Damas AM. Gales L, et al. Among authors: almeida mr. Biochim Biophys Acta. 2008 Mar;1784(3):512-7. doi: 10.1016/j.bbapap.2007.11.014. Epub 2007 Dec 3. Biochim Biophys Acta. 2008. PMID: 18155178

5

Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy.

Macedo B, Batista AR, Ferreira N, Almeida MR, Saraiva MJ. Macedo B, et al. Among authors: almeida mr. Biochim Biophys Acta. 2008 Sep;1782(9):517-22. doi: 10.1016/j.bbadis.2008.05.005. Epub 2008 Jun 3. Biochim Biophys Acta. 2008. PMID: 18572024 Free article.

6

Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.

Mairal T, Nieto J, Pinto M, Almeida MR, Gales L, Ballesteros A, Barluenga J, Pérez JJ, Vázquez JT, Centeno NB, Saraiva MJ, Damas AM, Planas A, Arsequell G, Valencia G. Mairal T, et al. Among authors: almeida mr. PLoS One. 2009;4(1):e4124. doi: 10.1371/journal.pone.0004124. Epub 2009 Jan 6. PLoS One. 2009. PMID: 19125186 Free PMC article.

7

Isatin derivatives, a novel class of transthyretin fibrillogenesis inhibitors.

González A, Quirante J, Nieto J, Almeida MR, Saraiva MJ, Planas A, Arsequell G, Valencia G. González A, et al. Among authors: almeida mr. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5270-3. doi: 10.1016/j.bmcl.2009.03.004. Epub 2009 Mar 6. Bioorg Med Chem Lett. 2009. PMID: 19651509

8

Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity.

Ferreira N, Cardoso I, Domingues MR, Vitorino R, Bastos M, Bai G, Saraiva MJ, Almeida MR. Ferreira N, et al. Among authors: almeida mr. FEBS Lett. 2009 Nov 19;583(22):3569-76. doi: 10.1016/j.febslet.2009.10.062. Epub 2009 Oct 25. FEBS Lett. 2009. PMID: 19861125 Free article.

9

Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation.

Ferreira N, Saraiva MJ, Almeida MR. Ferreira N, et al. Among authors: almeida mr. FEBS Lett. 2011 Aug 4;585(15):2424-30. doi: 10.1016/j.febslet.2011.06.030. Epub 2011 Jul 2. FEBS Lett. 2011. PMID: 21740906 Free article.

10

Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.

Ferreira N, Saraiva MJ, Almeida MR. Ferreira N, et al. Among authors: almeida mr. PLoS One. 2012;7(1):e29933. doi: 10.1371/journal.pone.0029933. Epub 2012 Jan 10. PLoS One. 2012. PMID: 22253829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

377 results

Search Page